{"entity":{"type":"insider","cik":"0001706301","url":"/insider/0001706301","json_url":"/insider/0001706301.json","name":"Noonberg Sarah B.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2021-02-12","last":"2025-06-09","span_basis":"filed_date"},"name_variants":[{"name":"Noonberg Sarah B.","source":"filing","n_filings":2,"first_seen":"2021-02-12","last_seen":"2025-06-09"}],"transactions":[{"id":4264459,"accession":"0000950170-25-083952","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-083952","line_url":"/filing/0000950170-25-083952#line-1","is_derivative":false,"issuer_cik":"0001706301","issuer_name":"Metagenomi, Inc.","issuer_ticker":"MGX","issuer_name_source":null,"issuer_url":"/issuer/0001706301","owner_cik":"0001706301","owner_name":"Noonberg Sarah B.","owner_display_name":"Noonberg Sarah B.","owner_url":"/insider/0001706301","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5239.0,"shares_display":"5,239","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":9168.25,"total_display":"9,168.25","total_whole":"9,168","shares_owned_after":109135.0,"shares_owned_after_display":"109,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-06","filed_date":"2025-06-09","scope":"insider"},{"id":4137843,"accession":"0001209191-21-010401","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-010401","line_url":"/filing/0001209191-21-010401#line-5","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001706301","owner_name":"Noonberg Sarah B.","owner_display_name":"Noonberg Sarah B.","owner_url":"/insider/0001706301","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":25.09,"price_display":"25.09","price_state":"stated","total_value":92833.0,"total_display":"92,833.00","total_whole":"92,833","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-12","scope":"insider"},{"id":4137839,"accession":"0001209191-21-010401","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-010401","line_url":"/filing/0001209191-21-010401","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001706301","owner_name":"Noonberg Sarah B.","owner_display_name":"Noonberg Sarah B.","owner_url":"/insider/0001706301","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4700.0,"shares_display":"4,700","price_per_share":25.472765957446807,"price_display":"25.47","price_state":"stated","total_value":119722.0,"total_display":"119,722.00","total_whole":"119,722","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-12","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001785279","name":"Metagenomi, Inc.","url":"/issuer/0001785279","role":"Officer (Chief Medical Officer)","n_filings":1,"first_seen":"2025-06-09","last_seen":"2025-06-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001377121","name":"Protagonist Therapeutics, Inc","url":"/issuer/0001377121","role":"Director","n_filings":1,"first_seen":"2021-02-12","last_seen":"2021-02-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001706301","retrieved_at":"2026-08-22T21:13:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}